FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37293102> ?p ?o ?g. }

• Q37293102 description "2009年學術文章" @default.
• Q37293102 description "article científic" @default.
• Q37293102 description "article scientifique" @default.
• Q37293102 description "articolo scientifico" @default.
• Q37293102 description "artigo científico" @default.
• Q37293102 description "artículu científicu espublizáu en 2009" @default.
• Q37293102 description "bilimsel makale" @default.
• Q37293102 description "scholarly article" @default.
• Q37293102 description "vedecký článok" @default.
• Q37293102 description "vetenskaplig artikel" @default.
• Q37293102 description "videnskabelig artikel" @default.
• Q37293102 description "vědecký článek" @default.
• Q37293102 description "wetenschappelijk artikel" @default.
• Q37293102 description "wissenschaftlicher Artikel" @default.
• Q37293102 description "наукова стаття, опублікована в травні 2009" @default.
• Q37293102 description "научни чланак" @default.
• Q37293102 description "مقالة علمية نشرت في 26 مايو 2009" @default.
• Q37293102 name "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 name "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 name "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 type Item @default.
• Q37293102 label "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 label "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 label "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 prefLabel "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 prefLabel "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 prefLabel "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma." @default.
• Q37293102 P1433 Q37293102-946222FD-BCD6-49C2-9F8C-B2BBD2FDD622 @default.
• Q37293102 P1476 Q37293102-AEA51119-F64C-493F-AA8A-D03B99DA9B04 @default.
• Q37293102 P2093 Q37293102-1805F147-2401-433C-8A4F-E39B4E73E583 @default.
• Q37293102 P2093 Q37293102-2F0D157A-DAE5-46F3-A1DB-1B1C3BFED91B @default.
• Q37293102 P2093 Q37293102-416BAED9-8194-4D4B-9390-6D8201CCCA18 @default.
• Q37293102 P2093 Q37293102-7260A025-0A33-4593-8610-AE0D9CDBA4DE @default.
• Q37293102 P2093 Q37293102-7BFCD83F-5480-42E3-9D87-CFF9DC038254 @default.
• Q37293102 P2093 Q37293102-813E5528-E456-44A4-8331-D90244105A24 @default.
• Q37293102 P2093 Q37293102-972ADD4D-515E-4CCB-8278-DFF3EFFF2932 @default.
• Q37293102 P2093 Q37293102-C467E4A7-6FEB-410B-AC43-C0AB9C9C6348 @default.
• Q37293102 P2093 Q37293102-D3B23F7B-402C-4D24-AA1A-4373A519E8D1 @default.
• Q37293102 P2093 Q37293102-DDAF6A93-5BB8-4DC2-917D-30637B21C64D @default.
• Q37293102 P2860 Q37293102-01C5A5E9-1EAB-4BC7-BFAA-5CD672C796CC @default.
• Q37293102 P2860 Q37293102-079A89CC-48B9-4997-BEEE-FD357C808FC5 @default.
• Q37293102 P2860 Q37293102-099720D9-5298-4EAE-BD24-430F716371F8 @default.
• Q37293102 P2860 Q37293102-0BE7A365-04E9-47E7-AFC3-40A8A504BE21 @default.
• Q37293102 P2860 Q37293102-22847E94-3326-4040-86AC-68691C2D62D6 @default.
• Q37293102 P2860 Q37293102-36E3583C-F80B-4859-8C80-B02B80587B90 @default.
• Q37293102 P2860 Q37293102-3718FDEF-ECD6-4A22-8E08-86AA628460A2 @default.
• Q37293102 P2860 Q37293102-3993A0AF-A050-43AF-94C5-C09811E58D5A @default.
• Q37293102 P2860 Q37293102-485BC929-AB46-4D67-8FE3-3BBB816E316F @default.
• Q37293102 P2860 Q37293102-49905550-54A1-4880-83B3-BBFDC43CA01B @default.
• Q37293102 P2860 Q37293102-4D609A52-FB82-44D6-AD1F-0FC624E0A3C4 @default.
• Q37293102 P2860 Q37293102-4E981C45-6198-4873-8FD1-46F08DFDBCA4 @default.
• Q37293102 P2860 Q37293102-597BC2FC-FD5F-4AB9-9060-48AE014565AD @default.
• Q37293102 P2860 Q37293102-6212F3E9-EA7B-478B-9FAD-5CBAB702F30B @default.
• Q37293102 P2860 Q37293102-63E67783-12CE-49D8-9369-1F54E94CFFF2 @default.
• Q37293102 P2860 Q37293102-6BEFE522-1E5B-49A5-B14A-885E1F196595 @default.
• Q37293102 P2860 Q37293102-6E37BFD1-BE4C-4F7C-A399-AA12E87D4F52 @default.
• Q37293102 P2860 Q37293102-70768D86-C528-4FE6-89FD-261EDEDAA2F9 @default.
• Q37293102 P2860 Q37293102-7582F51A-E78F-4246-AC3B-4FC1D04B502F @default.
• Q37293102 P2860 Q37293102-77DF450F-F955-4F90-85E9-84342AC19576 @default.
• Q37293102 P2860 Q37293102-8FCE91F3-7FB6-40B4-9C66-331292A65676 @default.
• Q37293102 P2860 Q37293102-903ECF9E-683C-4970-9B3B-969D0BF55FD9 @default.
• Q37293102 P2860 Q37293102-A0AF3242-1F2B-4C2C-8D9B-39A18C04E617 @default.
• Q37293102 P2860 Q37293102-AAB000DA-EFA3-4BD2-A810-9EB812D868D4 @default.
• Q37293102 P2860 Q37293102-AB86149B-031D-4575-8E14-23321876C7D9 @default.
• Q37293102 P2860 Q37293102-AC953AF7-EF62-447D-89CD-3CFA77A3A74E @default.
• Q37293102 P2860 Q37293102-AE26DFD7-9581-453B-BC2F-B4945C7BF60C @default.
• Q37293102 P2860 Q37293102-AFCBE247-7EEC-4B2C-9E93-101A98C5A91A @default.
• Q37293102 P2860 Q37293102-BB56FD1F-E07E-41A4-963A-C9588E48292D @default.
• Q37293102 P2860 Q37293102-BF0750B2-7BE0-4CFA-BBF7-C40C9DF04909 @default.
• Q37293102 P2860 Q37293102-C33B00C8-9987-46AA-8E40-EB333492D7BE @default.
• Q37293102 P2860 Q37293102-C3ABEDF3-AE57-4B2F-B9CF-4EE99D767A0B @default.
• Q37293102 P2860 Q37293102-DF61B87F-0642-4656-836A-0A897602AA82 @default.
• Q37293102 P2860 Q37293102-FDA65093-82BA-49BD-B491-847833C2CC98 @default.
• Q37293102 P304 Q37293102-9044780D-2CC1-4D2B-900D-AB563A26CC79 @default.
• Q37293102 P31 Q37293102-65F57028-2661-43B7-BC02-32C48D2F0782 @default.
• Q37293102 P356 Q37293102-A124E98D-3628-428F-8B3F-3C12E6C0BEFA @default.
• Q37293102 P407 Q37293102-CEB4A6AA-AB32-42BC-8265-D3BBE2CDC822 @default.
• Q37293102 P433 Q37293102-29B5120F-14FC-49AF-AA66-57FE47B5EDC8 @default.
• Q37293102 P478 Q37293102-CB886EED-254C-41B2-8C3E-26434FC177E0 @default.
• Q37293102 P50 Q37293102-A2F8A16D-0F9B-4CA7-AED2-FD627B1953E5 @default.
• Q37293102 P50 Q37293102-AA303951-4692-4945-99C9-9910C25FAA3B @default.
• Q37293102 P50 Q37293102-B801F1A6-67ED-4E2D-9236-C4E1DE86AEEF @default.
• Q37293102 P50 Q37293102-EBA894E5-1A55-4714-B9E9-F73B9D840FB6 @default.
• Q37293102 P577 Q37293102-625E3ABE-9E0A-4147-BE32-5C03D17D378B @default.
• Q37293102 P5875 Q37293102-7248ABF3-4A1E-4B06-85EB-75D796586014 @default.
• Q37293102 P698 Q37293102-BEA93E02-0FE2-4E75-8C1D-7BC2D0317386 @default.
• Q37293102 P819 Q37293102-7409878C-B613-4A24-92CE-5DD4F715B889 @default.
• Q37293102 P921 Q37293102-6FFB5C72-1087-403E-B790-CA2EDDE3F60F @default.
• Q37293102 P932 Q37293102-3B4E59F1-1C5A-4922-A3F6-861BC1508DBD @default.
• Q37293102 P356 PNAS.0813055106 @default.
• Q37293102 P698 19470463 @default.
• Q37293102 P1433 Q1146531 @default.
• Q37293102 P1476 "Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma" @default.
• Q37293102 P2093 "Anita Galvez" @default.
• Q37293102 P2093 "Elias A Castilla" @default.
• Q37293102 P2093 "Jayashree Joshi" @default.
• Q37293102 P2093 "Jorge Moscat" @default.
• Q37293102 P2093 "Jose Palacios" @default.
• Q37293102 P2093 "Maria T Diaz-Meco" @default.
• Q37293102 P2093 "Marta Cañamero" @default.

• next